Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
Journal of the National Cancer Institute
|
December 1, 2012
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research
Joanne W Elena, Lois B Travis, Naoko I Simonds, et al.
Melanoma Research
|
March 4, 2021
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922)
Stergios J Moschos, Zeynep Eroglu, Nikhil I Khushalani, et al.
The British Journal of Dermatology
|
July 12, 2025
Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa
K Alaine Broadaway, Quan Sun, Sharon N Edmiston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2015
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
Craig C Carson, Stergios J Moschos, Sharon N Edmiston, et al.
JAMA Oncology
|
July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
Nancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Nature Communications
|
November 24, 2011
P-Rex1 is required for efficient melanoblast migration and melanoma metastasis
Colin R Lindsay, Samuel Lawn, Andrew D Campbell, et al.
Frontiers in Oncology
|
January 22, 2019
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
Xiaobei Zhao, Paul Little, Alan P Hoyle, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
The state of melanoma: challenges and opportunities
Glenn Merlino, Meenhard Herlyn, David E Fisher, et al.
Pigment Cell & Melanoma Research
|
July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
Li Luo, Ronglai Shen, Arshi Arora, et al.
JCO Precision Oncology
|
November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance
Kathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
Journal of the National Cancer Institute
|
December 1, 2012
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research
Joanne W Elena, Lois B Travis, Naoko I Simonds, et al.
Melanoma Research
|
March 4, 2021
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922)
Stergios J Moschos, Zeynep Eroglu, Nikhil I Khushalani, et al.
The British Journal of Dermatology
|
July 12, 2025
Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa
K Alaine Broadaway, Quan Sun, Sharon N Edmiston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2015
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
Craig C Carson, Stergios J Moschos, Sharon N Edmiston, et al.
JAMA Oncology
|
July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
Nancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Nature Communications
|
November 24, 2011
P-Rex1 is required for efficient melanoblast migration and melanoma metastasis
Colin R Lindsay, Samuel Lawn, Andrew D Campbell, et al.
Frontiers in Oncology
|
January 22, 2019
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
Xiaobei Zhao, Paul Little, Alan P Hoyle, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
The state of melanoma: challenges and opportunities
Glenn Merlino, Meenhard Herlyn, David E Fisher, et al.
Pigment Cell & Melanoma Research
|
July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
Li Luo, Ronglai Shen, Arshi Arora, et al.
JCO Precision Oncology
|
November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance
Kathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Page
of 13